Chapter 2 Lec Flashcards

0
Q

Differentiate the effect and potency of the test agent from those of control

A

Bioassaya

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Ability of cells w the potential to produce a desired antibody

A

Monoclonal antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Body’s means of transforming nonpolar molecules to polar compounds

A

Biochemical transformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Useful in treatment of diabetes mellitus

Also has anti tumor capabilities

A

Periwinkle or vinca rosea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Chemical alteration

A

Molecular modification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Basic techniques that has the ability to manipulate and produce proteins

A

Recombinant DNA and monoclonal antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Has the potential to produce any protein

Genetic material can be transplanted from higher species to a lowly bacteriun

A

Recombinant dna

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Medical intervention based on the modification of the genetic material

A

Human gene therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Molecular modification to design a drig that interferes with the known biochemical pathway

A

Mechanism based drug design

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Produce the specifically desired effect

No side effects

A

Goal drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Undertaken to reveal any effect of an active ingredient on mammalian reprod

A

Reproduction studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Clinical trial materials

A

New drug, placebo and the drug product which the new prof is to be compared

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Prototype chemical compound that had a fundamental desired biologic or pharmacologic activity

A

Lead compound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Involves testingg of large numbers of synthetic organic compounds

A

Random or un targeted screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

A compound that requires metabolic biotransformatiin after administration to produce the desired pharmacologically active compound

A

Prodrug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Allows vets to prescribe extra label uses or animal drugs and human drugs for animals

A

Animal medicinal drug use of clarification act of 1994

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

2 animal species for drug metabolism

A

Rodent and dog

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Special care of the prescriber and patient in the use of the drug

A

Precautions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

First pass effect

A

Drugs thru liver and exposure to hepatic enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

45% sucess

A

Phase 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

20-100 subjects

A

Phase I- healthy subjects

27
Q

Controlled in which atleast one of the parties does not know which producy is being administered

A

Blind studies

30
Q

Quantitative range or amount of drug that may be prescribed safely

A

Usual dosage rangr

32
Q

2 weeks at 3 dosage lvls to 2 animals

A

Subacute or subchronic studies

33
Used to gather supplemental info that may contain support certain labeling requests
Phase 3b studied
34
To test if the comp can affect gene mutation
Genotoxicity
35
Speed at which a drug substance dissolves in a medium
Dissolution rate
36
Undertake when the comp has shown sufficient promise as a drug to enter human clinical trials Carried out in rats and mouse strains 18-24 months
Carcinogenic studies
37
Orphan drug act of 1983
Rare diseases that affects lower than 200,000 people
38
Objective is to make promising drugs available to desperately ill patients
Treatment IND
40
67% success
Phase I
41
Controlled clinical studied to evaluate effectiveness of a drug in patients with the condition for which the drug is intended for
Phase 2- unhealthy subjects
43
100-1000 patients Last for 1-4 trs Safety effectiveness and sosge 5-10%
Phase 3
44
Fda approved indication prevention or diagnosis
Indication and usage
45
May influence a drugs action by altering its pharmacokinetic profile
Genetic polymorphism
46
Amount that is enough to achieve the drugs optimum therapeutic effect
Dose of drug
47
Nonclinical lab studied may be omitted | Duplicates or generic copies
Abbreviated new drug application
48
Predictable and unpredictable undesired effects
Adverse rxns
49
Descriptjon of the adverse reactions and safety hazards
Warnings
50
Summary of all actions of drugs
Clinical pharmacology
51
A tranquilizer and a hypotensive agent
Reserpine
52
First human gene therapy
Adenosine deaminase deficiency
53
Risk of use clearly outweighs any beneficial effecy
Contraindication
55
Biochemical transformation results in..?
Production of metabolites
59
Ability to endure the influence of the drug
Tolerance
60
Rectal buccal administration
Drugs are absorbed into the systemic circularion through blood vessels
62
Initial intro | Purpose of assessing safety
Phase I - healthy subjects
66
deals w the adverse or undesired effects of drugs
Toxicology
69
Capable of examining 15,000 chem compounds a week using 10-20 biologic assays
High throughout screening
76
Determine the toxic effects over a short period of time
Acute toxicity studies